Inhibition of adrenal steroidogenesis by danazol in vivo.
D006907:17-alpha-Hydroxypregnenolone / Q000096:biosynthesis; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D000735:Androstenedione / Q000096:biosynthesis; D003350:Cortodoxone / Q000096:biosynthesis; D003613:Danazol / Q000097:blood / Q000494:pharmacology*; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D005260:Female; D006801:Humans; D011245:Pregnadienes / Q000494:pharmacology*; D011284:Pregnenolone / Q000096:biosynthesis; D011374:Progesterone / Q000096:biosynthesis; D013256:Steroids / Q000096:biosynthesis*; D013997:Time Factors
D011245:Pregnadienes; D013256:Steroids; D006907:17-alpha-Hydroxypregnenolone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D011374:Progesterone; D011284:Pregnenolone; D000324:Adrenocorticotropic Hormone; D003613:Danazol; D003350:Cortodoxone